ANNOUNCEMENT: RXIX POSTPONEMENT TO 2022
Dear Recovery Colleagues,
In view of the ongoing and ever-changing public health crisis due to the coronavirus outbreak, the Recovery Conference Co-Chairs and Board of Directors have made the difficult decision to postpone further Recovery of Biological Products XIX (RXIX) in Rome, Italy to 2022. By moving to 2022, we hope it will alleviate any health concerns, as well as avoid travel restrictions that may limit the ability to travel to the conference.
Given the postponement of the conference, we will be re-opening the call for abstracts in the Fall of 2021 and repeating the abstract selection process afresh. To be considered for the rescheduled conference dates in 2022, submitters will have the opportunity to either submit completely new abstracts or to update and resubmit their original abstracts.
We are sincerely grateful for the time, dedication and patience of the Recovery Board of Directors, Sponsors, Session Chairs, and Abstract Submitters who make this conference possible. It is our intention to deliver an incredible conference in 2022.
The outbreak has focused the world’s attention on the tremendous contributions that we can make in this sector as well as the urgency for more rapid development of biologics with appropriate regulatory flexibility to facilitate moving at pandemic speed. With this in mind, we are convinced that getting together is more important than ever and so we look forward to your presence at this exciting conference in 2022.
In the meantime, we are excited to announce that Recovery will be running virtual Satellite Meetings designed to maintain the involvement and momentum of the Recovery community. Please look out for more detailed announcements and updates via the Recovery website and email. We look forward to connecting throughout the upcoming year!
The RXIX Co-Chairs
Suzy Farid (UCL, UK), Nihal Tugcu (Sanofi, USA), Arne Staby (Novo Nordisk, Denmark)
Welcome to the Recovery of Biological Products Conference Series
The Recovery of Biological Products Conference Series is the premier international forum for the presentation and discussion of recent advances in the operations used to recover biological products of therapeutic, diagnostic and industrial value to society. An invitation-only biennial event, the Conference Series provides delegates with a clear and comprehensive understanding of the status and direction of this fast-moving field.
Sponsored by the American Chemical Society, Division of Biochemical Technology (BIOT), this international conference provides exposure to the latest developments in bioprocessing with a focus on downstream processing and aspects that affect the downstream steps. Unparalleled opportunities to network with industry leaders are a key feature of the conference. The size, venue and schedule of the meeting are specifically designed to provide multiple opportunities for discussion and development of new areas and concepts relating to the separation, purification and efficient processing of biological products. The Conference Series is a Not-for-Profit 501(c) (3) organization.
The co-chairs of Recovery of Biological Products XIX are pleased to announce that the next conference will be held in 2022 at the Rome Cavalieri, Rome, Italy. This readily accessible, world-class facility provides a new and outstanding venue for the conference.
The theme for RXIX is "Past, Present, Future", and the conference will bring together top academic and industrial scientists and engineers to stimulate discussions about how best to innovate to move our field forward in the face of considerable challenges.
In addition to the oral sessions, the conference will include a stimulating set of poster sessions, keynote addresses and special sessions designed to allow all delegates to contribute their scientific and technical knowledge to the entire delegation.